Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study

PURPOSE: Antivascular endothelial growth factor (anti-VEGF) therapy is a promising treatment approach for patients with recurrent glioblastoma. This single-arm phase II study evaluated the efficacy of aflibercept (VEGF Trap), a recombinantly produced fusion protein that scavenges both VEGF and place...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: de Groot, John F., Lamborn, Kathleen R., Chang, Susan M., Gilbert, Mark R., Cloughesy, Timothy F., Aldape, Kenneth, Yao, Jun, Jackson, Edward F., Lieberman, Frank, Robins, H. Ian, Mehta, Minesh P., Lassman, Andrew B., DeAngelis, Lisa M., Yung, W.K. Alfred, Chen, Alice, Prados, Michael D., Wen, Patrick Y.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2011
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3139373/
https://ncbi.nlm.nih.gov/pubmed/21606416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.34.1636
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak